Results 231 to 240 of about 145,206 (314)

Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501)

open access: yesGastric Cancer, 2019
M. Terashima   +16 more
semanticscholar   +1 more source

GLP‐1 receptor agonists for treating obesity without diabetes: A systematic review and meta‐analysis of economic evaluations

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1339-1349, February 2026.
Abstract Aim To pool the incremental net benefits (INBs) of using glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) for treating obesity without diabetes. Materials and Methods PubMed, Embase, EconLit, CEA Registry, ProQuest Dissertation and Theses Global were searched from inception to April 2024.
Teerapon Dhippayom   +7 more
wiley   +1 more source

The Changing Landscape of Hereditary Diffuse Gastric Cancer. [PDF]

open access: yesJ Gastric Cancer
Vaessen C   +3 more
europepmc   +1 more source

Demographics and blood groups as predictors of weight loss after laparoscopic sleeve gastrectomy

open access: gold
Walid M. Abd El Maksoud   +11 more
openalex   +1 more source

Case Report of Gastrojejunostomy Intussusception after Gastrectomy with Roux-en-Y Reconstruction

open access: diamond, 2015
T. Aizawa   +5 more
openalex   +2 more sources

Single-arm confirmatory trial of laparoscopy-assisted total or proximal gastrectomy with nodal dissection for clinical stage I gastric cancer: Japan Clinical Oncology Group study JCOG1401

open access: yesGastric Cancer, 2018
H. Katai   +13 more
semanticscholar   +1 more source

Changes in Components of Sarcopenia Diagnostic Criteria Throughout the Surgical Treatment of Oesophagogastric Cancer Surgery: A Prospective Longitudinal Study

open access: yesJournal of Human Nutrition and Dietetics, Volume 39, Issue 1, February 2026.
ABSTRACT Introduction Low skeletal muscle is prevalent and associated with poorer outcomes after oesophagogastric (OG) cancer surgery. However, sarcopenia, including strength and function, is less commonly assessed. Therefore, we aimed to describe the prevalence of sarcopenia and changes in diagnostic criteria within 1 year of OG cancer surgery ...
Lisa C. Murnane   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy